98%
921
2 minutes
20
Purpose: The current study aimed to evaluate the feasibility of RetinoQuest in clinical practice, from survivors and healthcare professionals' (HCPs) point of view.
Methods: RetinoQuest is a touch screen computer program to monitor health-related quality of life (HRQoL) of retinoblastoma survivors via patient-reported outcome measures (PROMs) targeting children (4-10 years) as evaluated by their parents (proxy measures), adolescents (11-18 years), and adults. Feasibility was evaluated by the actual time taken to complete the PROMs, acceptability of the time as perceived by the users, the content of PROMs in RetinoQuest, and overall satisfaction with RetinoQuest.
Results: Ninety-six survivors participated: 41 parents of children, 38 adolescents, and 17 adults. Mean time to complete the evaluation form was 7.8 min (median 6.7, range 2.4-24.5), and 90% of the users stated that the time needed to complete PROMs in RetinoQuest was acceptable. The majority of users reported that it was important to answer the questions (88% of the parents, 66% of the adolescents, and 76% of the adult survivors) and that all important issues were covered, e.g., no missing questions (78, 84, and 76%, respectively). Satisfaction rate was high, 7.8 according to parents, 8.1 according to adolescents, and 7.7 for adults.
Conclusions: RetinoQuest is a feasible e-health application to monitor HRQoL in retinoblastoma survivors in clinical practice.
Implications For Cancer Survivors: This tool allows for open and structured communication which can lead to early detection of psychosocial impacts on quality of life and referral of the retinoblastoma survivors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671548 | PMC |
http://dx.doi.org/10.1007/s11764-017-0642-z | DOI Listing |
BMC Psychiatry
September 2025
Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200025, P.R. China.
Background: Recent studies indicate parents of childhood cancer survivors experience high psychological burden. However, there is limited knowledge regarding the mental health of parents of children with retinoblastoma (RB) in China. Thus, the purpose of this study was to assess anxiety, depression, fear of disease progression (FoP), and family function among parents of children with RB, and to analyze associated factors.
View Article and Find Full Text PDFJ Pediatr Ophthalmol Strabismus
July 2025
Retinoblastoma, a potentially fatal pediatric intraocular malignancy, is now curable with intravenous and intra-arterial (IAC) chemotherapy. In this report, the authors describe globe volume asymmetry, a lesser-known sequela of IAC, as well as the hemodynamics of a tumor-laden eye, pattern of eyeball growth following IAC, and potential mechanisms of amblyopia in retinoblastoma survivors. .
View Article and Find Full Text PDFPediatr Blood Cancer
October 2025
Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background: The chemotherapy regimen comprising carboplatin, vincristine, and etoposide (JOE) is commonly used to treat retinoblastoma. Carboplatin-induced ototoxicity is infrequently reported. Extended high-frequency hearing loss may impair cochlear function and speech-in-noise recognition and elevate hearing thresholds.
View Article and Find Full Text PDFExpert Rev Anticancer Ther
July 2025
Department of Ophthalmology, Opty Group, Rio de Janeiro, Brazil.
Introduction: Retinoblastoma is the most common intraocular malignancy in children. Although survival has improved with multimodal therapy, survivors remain at risk for subsequent malignant neoplasms (SMNs), often due to prior treatments or genetic predisposition. To identify risk factors associated with SMNs in childhood retinoblastoma survivors.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
June 2025
Department of Ophthalmology, Westmead Hospital.
Purpose: Retinoblastoma (RB) is the most common intraocular tumor in childhood. Survivors of RB are at risk of developing secondary malignancies. Prior radiotherapy substantially increases the risk of malignancy in the orbit, brain, and nasal cavities.
View Article and Find Full Text PDF